Concepedia

Matthew Pine

MP

6

Publications

1.1K

Citations

6

H-Index

2018

Active since

Affiliations

Acuitas Therapeutics (Canada)(Current)

University of Pennsylvania

Icahn School of Medicine at Mount Sinai

Matthew Pine is an author at Acuitas Therapeutics (Canada) specializing in vaccine development, vaccination, and immunology.

ORCID

Top concepts

Publications per year

2018–2023

6

Publications

6

Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses

Mohamad‐Gabriel Alameh, István Tombácz, Emily Bettini et al. · Immunity · 2021 · 659 citations · Full text

, , +11

A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice

Alec W. Freyn, Jamile Ramos da Silva, Victoria Rosado et al. · Molecular Therapy · 2020 · 294 citations · Full text

Development of an mRNA-lipid nanoparticle vaccine against Lyme disease

Matthew Pine, Gunjan Arora, Thomas Hart et al. · Molecular Therapy · 2023 · 70 citations · Full text

Antigen modifications improve nucleoside-modified mRNA-based influenza virus vaccines in mice

Alec W. Freyn, Matthew Pine, Victoria Rosado et al. · Molecular Therapy — Methods & Clinical Development · 2021 · 37 citations · Full text

A novel method for strict intranasal delivery of non-replicating RSV vaccines in cotton rats and non-human primates

Michael Citron, Manishkumar Patel, Mona Purcell et al. · Vaccine · 2018 · 23 citations · Full text

, , +17

Rows per page

1–5 of 6